Impact on hospitals of price reductions for physician-administered biologics
{{output}}
The prices of physician-administered drugs and biologics are coming under downward pressures from Medicare price negotiations, Most Favored Nation policies, and competition from biosimilars. These will reduce manufacturer sales revenue but potentially increase... ...
